No Title Presenter Date
1037 VH-IVUS Findings of Thin-Capped Fibroatheroma in ACS Sang-Wook Kim Dec. 03. 09
1036 Efficacy and Safety of Dabigatran Compared to Warfarin at Different Levels of INR Control for Stroke Prevention in 18,113 patients with Atrial Fibrillation in the RE-LY Trial Lars Wallentin Dec. 02. 09
1035 Randomised Dabigatran Etexilate Dose Finding Study In Patients With Acute Coronary Syndromes Post Index Event With Additional Risk Factors For Cardiovascular Complications Also Receiving Aspirin and Clopidogrel J Oldgren Dec. 02. 09
1034 Differences in Clinical Outcomes with Rhythm and Rate Control Therapies for Atrial Fibrillation in the RecordAF Registry A. John Camm Dec. 02. 09
1033 Radial Access Versus Conventional Femoral Puncture: Outcome and Resource Effectiveness in a Daily Routine. The RAPTOR-Trial Tim G. Schäufele Dec. 02. 09
1032 Do Platelet Function Assays Predict Clinical Outcomes in clopidogrel pretreated patients undergoing elective PCI Nicoline J Breet Dec. 02. 09
1031 Non-Steroidal Anti-Inflammatory (NSAIDs) Treatment for Post-Operative Pericardial Effusion: The POPE Study : A Multicenter, Double-Blind, Randomized Trial Ph Meurin Dec. 02. 09
1030 Outcomes in patients with STEMI and planned PCI Ph.Gabriel Steg Dec. 02. 09
1029 Paclitaxel-Eluting PTCA-Balloon in Combination with the Coroflex Blue Stent vs the Sirolimus Coated Cypher Stent in the Treatment of Advanced Coronary Artery Disease C. W. Hamm Dec. 02. 09
1028 Long-term Cardiac and NeurocognitiveOutcome After Off- pump Coronary Artery Bypass Grafting (OPCAB) Versus PercutaneousCoronary Intervention (PCI) Jakub J Regieli Dec. 02. 09